ATL-313 and dexamethasone have synergistic antitumor effect in models of multiple myeloma Dec. 15, 2010
Adding ganitumab to exemestane or fulvestrant does not improve PFS in patients with breast cancer Dec. 13, 2010
Safety and preliminary antitumor activity of CEP-18770 reported in first-in-human study Dec. 13, 2010